In September 2020, global biotech CSL announced it would manufacture the University of Oxford/AstraZeneca AZD1222 COVID-19 vaccine candidate in Australia. Since then 13 million doses went into the arms of Australians and more than 8 million doses left Australia to assist other nations. Check out the graphic above to see where doses of Vaxzevria have been donated.
Indonesia for example, was hit hard by the Delta variant, hitting over 50,000 new cases a day in June. With the help of vaccines though, this has now been reduced to just 176.
Speaking at the FY21 Annual General Meeting, CSL Chair Brian McNamee said, “We are pleased to say that the Australian Government and AstraZeneca trusted us as their partners to help the country respond to the emerging crisis through the most effective solution available: vaccination.”